Global pharmaceutical data and analytics market to double by 2028

China represents the largest market for the sector.

The global data and analytics market in the pharmaceutical sector, valued at $1.1b in 2022, is projected to reach $2.1b in 2028, according to GlobalData.

The sector’s expansion is attributed to advancements in data and content management.

China represents the largest market for the sector, accounting for approximately 20.2% of global sales in 2022, with this share expected to increase to 25.9% by 2028.

“As the pharmaceutical industry becomes more digitised with an increasing quantity of complex and vast dataset sources produced, big data becomes increasingly crucial for growth and innovation within the pharmaceutical industry,” said Gaffar Aga, Strategic Intelligence Analyst at GlobalData.